Search

everythinglearnresearchcommunity

for

Search:↓

No treatment fully prevents hair loss from chemotherapy yet.

Some common medications can harm male fertility, but many effects can be reversed.

Some chemotherapy can cause permanent hair loss.

Scalp cooling can reduce chemotherapy-induced hair loss and should be available in all hospitals.

Hair usually grows back 1-3 months after treatment for anagen effluvium, and children with Loose Anagen Hair Syndrome often improve by adolescence.

Hair loss can indicate underlying systemic diseases and addressing these can sometimes reverse the hair loss.

Chemotherapy often causes hair loss, nail changes, and mouth issues, but these are usually manageable.

Cancer treatments often cause hair disorders, significantly affecting patients' quality of life, and better management methods are needed.

Many patients find hair loss from chemotherapy very distressing, and while treatments like minoxidil and scalp cooling may help, there is no sure way to prevent it.

Some breast cancer patients developed permanent hair loss after chemotherapy and hormonal therapy, showing patterns similar to common baldness and alopecia areata.

Chemotherapy can cause rapid, extensive hair loss, with patterns varying between individuals.

Hair loss in cancer patients can be related to the cancer itself, treatment, or other conditions, and understanding it is important for diagnosis and patient care.

Skin problems are common after stem cell transplants, and early treatment by dermatologists can improve patient outcomes.

Stress, nutritional issues, and chronic diseases can cause hair loss, and nail changes may signal internal diseases; treatment focuses on the underlying cause.

The document says that there are treatments for hair and nail diseases.

PRP therapy may help with ovarian issues and fertility, but more research is needed.

There's an urgent need for better treatments for hair loss caused by radiation therapy.

The document provides 70 multiple choice questions to improve haematology skills.

The document tests knowledge and decision-making in hematology through multiple-choice questions.

Treatments for acute leukaemia lead to high remission rates, but relapses occur, requiring ongoing advancements in care.

Some cancer and immune system drugs can cause serious side effects, including heart, lung, nerve, and organ damage, which need careful monitoring and management.

Chemotherapy in the first trimester of pregnancy is risky, but in the second and third trimesters, it's generally safe with careful drug selection and timing.

Anticancer drugs are increasingly found in surface waters, and their long-term environmental effects are not well understood, requiring better testing methods.

Iron deficiency may be related to hair loss, but there's not enough evidence to recommend iron screening or supplements for all hair loss patients.

Transplant success has improved with better immunosuppressive drugs and donor matching.

Over one-third of women experience hair loss, with female-pattern hair loss being most common, and treatments include minoxidil and possibly hair transplantation.

Postinflammatory hyperpigmentation causes dark skin patches and needs personalized treatment.

Cancer therapy can cause various skin problems, including hair loss, skin darkening, painful hand-foot syndrome, and severe skin damage.

Treatments for melanin disorders exist, but more effective options needed.

Docetaxel and paclitaxel for breast cancer can cause permanent, severe hair loss.